744
Views
32
CrossRef citations to date
0
Altmetric
Review

Antibiotic resistance propagation through probiotics

, ORCID Icon & ORCID Icon
Pages 1207-1215 | Received 28 May 2020, Accepted 14 Sep 2020, Published online: 27 Sep 2020

References

  • Vandenplas Y, Huys G, Daube G. Probiotics: an update. J De Pediatria (Versão Em Português). 2015;91(1):6–21.
  • Watts JE, Schreier HJ, Lanska L, et al. The rising tide of antimicrobial resistance in aquaculture: sources, sinks and solutions. Mar Drugs. 2017;15(6):158.
  • Mousavi T, Nikfar S, Abdollahi M. An update on efficacy and safety considerations for the latest drugs used to treat irritable bowel syndrome. Expert Opin Drug Metab Toxicol. 2020;16:583–604.
  • Amara AA, Shibl A. Role of Probiotics in health improvement, infection control and disease treatment and management. Saudi Pharm J. 2015;23(2):107–114.
  • So SS, Wan ML, El-Nezami H. Probiotics-mediated suppression of cancer. Curr Opin Oncol. 2017;29(1):62–72.
  • Ishimwe N, Daliri EB, Lee BH, et al. The perspective on cholesterol‐lowering mechanisms of probiotics. Mol Nutr Food Res. 2015;59(1):94–105.
  • Zheng M, Zhang R, Tian X, et al. Assessing the risk of probiotic dietary supplements in the context of antibiotic resistance. Front Microbiol. 2017;8:908.
  • Sotoudegan F, Daniali M, Hassani S, et al. Reappraisal of probiotics’ safety in human. Food Chem Toxicol. 2019;129:22–29.
  • Didari T, Solki S, Mozaffari S, et al. A systematic review of the safety of probiotics. Expert Opin Drug Saf. 2014;13(2):227–239.
  • Mancino W, Lugli GA, van Sinderen D, et al. Mobilome and resistome reconstruction from genomes belonging to members of the bifidobacterium genus. Microorganisms. 2019;7(12):638.
  • Jandhyala SM, Talukdar R, Subramanyam C, et al. Role of the normal gut microbiota. World J Gastroenterol. 2015;21(29):8787.
  • Mantegazza C, Molinari P, D’Auria E, et al. Probiotics and antibiotic-associated diarrhea in children: A review and new evidence on Lactobacillus rhamnosus GG during and after antibiotic treatment. Pharmacol Res. 2018;128:63–72.
  • Gueimonde M, Sánchez B, de Los Reyes-gavilán CG, et al. Antibiotic resistance in probiotic bacteria. Front Microbiol. 2013;4:202.
  • Lewies A, Du Plessis LH, Wentzel JF. Antimicrobial peptides: the Achilles’ heel of antibiotic resistance? Probiotics Antimicrob Proteins. 2019;11(2):370–381.
  • Mayrhofer S, Van Hoek AH, Mair C, et al. Antibiotic susceptibility of members of the Lactobacillus acidophilus group using broth microdilution and molecular identification of their resistance determinants. Int J Food Microbiol. 2010;144(1):81–87.
  • Schei K, Avershina E, Øien T, et al. Early gut mycobiota and mother-offspring transfer. Microbiome. 2017;5(1):107.
  • Dotterud CK, Avershina E, Sekelja M, et al. Does maternal perinatal probiotic supplementation alter the intestinal microbiota of mother and child? J Pediatr Gastroenterol Nutr. 2015;61(2):200–207.
  • Butel MJ. Probiotics, gut microbiota and health. Médecine et maladies infectieuses. 2014;44(1):1–8.
  • Das DJ, Shankar A, Johnson JB, et al. Critical insights into antibiotic resistance transferability in probiotic Lactobacillus. Nutrition. 2020;69:110567.
  • Roca I, Akova M, Baquero F, et al. The global threat of antimicrobial resistance: science for intervention. New Microbes New Infect. 2015;6:22–29.
  • Bilal M, Rasheed T, Iqbal HM, et al. Macromolecular agents with antimicrobial potentialities: a drive to combat antimicrobial resistance. Int J Biol Macromol. 2017;103:554–574.
  • WHO. Int. antimicrobial resistance; 2020 [cited 2020 May 22]. Available from: https://www.who.int/health-topics/antimicrobial-resistance
  • World Health Organization. Joint FAO/OIE/WHO Expert Workshop on Non-Human Antimicrobial Usage and Antimicrobial Resistance: scientific Assessment; 2003 Dec 1–5; Geneva: World Health Organization; 2004.
  • McEwen SA, Collignon PJ. Antimicrobial resistance: a one health perspective. Antimicrob Resistance Bacteria Livestock Companion Anim. 2018;(25):521–547.
  • Haberecht HB, Nealon NJ, Gilliland JR, et al. Antimicrobial-resistant Escherichia coli from environmental waters in northern Colorado. J Environ Public Health. 2019;18:2019.
  • Nirwati H, Sinanjung K, Fahrunissa F, et al. Biofilm formation and antibiotic resistance of Klebsiella pneumoniae isolated from clinical samples in a tertiary care hospital, Klaten, Indonesia. In BMC Proc. 2019;13(11):1–8.
  • Kidd TJ, Mills G, Sá‐Pessoa J, et al. A Klebsiella pneumoniae antibiotic resistance mechanism that subdues host defences and promotes virulence. EMBO Mol Med. 2017;9(4):430–447.
  • Farkas A, Tacro E, Butiuc-Keul A. Antibiotic resistance profiling of pathogenic Enterobacteriaceae from Cluj-Napoca. Germs. 2019;9(1):17.
  • Iredell J, Brown J, Tagg K. Antibiotic resistance in Enterobacteriaceae: mechanisms and clinical implications. BMJ. 2016;352:h6420.
  • Lambert PA. Mechanisms of antibiotic resistance in Pseudomonas aeruginosa. J R Soc Med. 2002;95:22.
  • Khaledi A, Weimann A, Schniederjans M, et al. Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning‐enabled molecular diagnostics. EMBO Mol Med. 2020;12(3):e10264.
  • Ali J, Rafiq QA, Ratcliffe E. Antimicrobial resistance mechanisms and potential synthetic treatments. Future Sci OA. 2018;4(4):FSO290.
  • Miller WR, Munita JM, Arias CA. Mechanisms of antibiotic resistance in enterococci. Expert Rev Anti Infect Ther. 2014;12(10):1221–1236.
  • Antibiotic/Antimicrobial Resistance. CDC. Antibiotic resistance threats in the United States; 2013 [cited 2020 May 22]. Available from: https://www.cdc.gov/drugresistance/biggest-threats.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fdrugresistance%2Fbiggest_threats.html
  • Alexander BD, Johnson MD, Pfeiffer CD, et al. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clinl Infect Dis. 2013;56(12):1724–1732.
  • Müller B, Borrell S, Rose G, et al. The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis. Trends Genet. 2013;29(3):160–169.
  • Chang S, Sievert DM, Hageman JC, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med. 2003;348(14):1342–1347.
  • Leisner JJ, Jørgensen NO, Middelboe M. Predation and selection for antibiotic resistance in natural environments. Evol Appl. 2016;9(3):427–434.
  • Fuller R. History and development of probiotics. InProbiotics. Dordrecht: Springer; 1992. p. 1–8.
  • www.who.int [Internet]. London, Ontario: FAO and WHO; [ cited 2019 Dec 27]. Available from: https://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf
  • Doron S, Snydman DR. Risk and safety of probiotics. Clinl Infect Dis. 2015;60(suppl_2):S129–34.
  • Soccol CR, Prado MR, Garcia LM, et al. Current developments in probiotics. J Microb Biochem Technol. 2014;7:11–20.
  • de Melo Pereira GV, de Oliveira Coelho B, Júnior AI, et al. How to select a probiotic? A review and update of methods and criteria. Biotechnol Adv. 2018;36(8):2060–2076.
  • National Institute of Health (NIH). Probiotics, fact sheet for health professionals, Hune 3, 2020; [ cited 2020 Aug 19]. Available at: https://ods.od.nih.gov/factsheets/Probiotics-HealthProfessional/#:~:text=The%20seven%20core%20genera%20of,commercial%20strains%20of%20probiotic%20organisms
  • Plessas S, Nouska C, Karapetsas A, et al. Isolation, characterization and evaluation of the probiotic potential of a novel Lactobacillus strain isolated from Feta-type cheese. Food Chem. 2017;226:102–108.
  • Sornplang P, Piyadeatsoontorn S. Probiotic isolates from unconventional sources: a review. J Anim Sci Technol. 2016;58(1):26.
  • García-Hernández Y, Pérez-Sánchez T, Boucourt R, et al. Isolation, characterization and evaluation of probiotic lactic acid bacteria for potential use in animal production. Res Vet Sci. 2016;108:125–132.
  • Mendes HB, Plaza-Diaz J, Bomfim MR, et al. Technology prospecting of infant stool as a source of novel probiotic products. Revista GEINTEC-Gestão, Inovação E Tecnologias. 2018;8(1):4240–4249.
  • Lemas DJ, Yee S, Cacho N, et al. Exploring the contribution of maternal antibiotics and breastfeeding to development of the infant microbiome and pediatric obesity. InSem Fetal Neonatal Med. 2016;21(6):406–409.
  • Garcia‐Mantrana I, Collado MC. Obesity and overweight: impact on maternal and milk microbiome and their role for infant health and nutrition. Mol Nutr Food Res. 2016;60(8):1865–1875.
  • VlainiĦ J, Suran J, Letizia Vukorep A. Probiotics as an adjuvant therapy in major depressive disorder. Curr Neuropharmacol. 2016;14(8):952–958.
  • Daniali M, Nikfar S, Abdollahi M. A brief overview on the use of probiotics to treat overweight and obese patients.
  • Galdeano CM, Cazorla SI, Dumit JM, et al. Beneficial effects of probiotic consumption on the immune system. Ann Nutr Metab. 2019;74(2):115–124.
  • Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol. 2014;24(10):R453–62.
  • Hosseini A, Nikfar S, Abdollahi M. Are probiotics effective in management of irritable bowel syndrome? Arch Med Sci. 2012;8(3):403.
  • Watson RR, Preedy VR, editors. Probiotics, prebiotics, and synbiotics: bioactive foods in health promotion. Academic Press; 2015:12–43.
  • Joint FAO/WHO Working Group Report. On drafting guidelines for the evaluation of probiotics in food. London, Canada; [ cited 2002 Apr/May 30. http://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf
  • Selvin J, Maity D, Sajayan A, et al. Revealing antibiotic resistance in therapeutic and dietary probiotic supplements. J Glob Antimicrob Resist. 2020;22:202–205.
  • Kothari D, Patel S, Kim SK. Probiotic supplements might not be universally-effective and safe: A review. Biomed Pharmacother. 2019;111:537–547.
  • Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 1995;39(6):1211.
  • Davies JE. Origins, acquisition and dissemination of antibiotic resistance determinants. InCiba Found Symp. 1997;207:15–27.
  • Courvalin P. Predictable and unpredictable evolution of antibiotic resistance. J Intern Med. 2008;264(1):4–16.
  • Sakamoto K, Konings WN. Beer spoilage bacteria and hop resistance. Int J Food Microbiol. 2003;89(2–3):105–124.
  • Smillie CS, Smith MB, Friedman J, et al. Ecology drives a global network of gene exchange connecting the human microbiome. Nature. 2011;480(7376):241–244.
  • Seville LA, Patterson AJ, Scott KP, et al. Distribution of tetracycline and erythromycin resistance genes among human oral and fecal metagenomic DNA. Microbial Drug Resist. 2009;15(3):159–166.
  • Ready D, Bedi R, Spratt DA, et al. Prevalence, proportions, and identities of antibiotic-resistant bacteria in the oral microflora of healthy children. Microbial Drug Resist. 2003;9(4):367–372.
  • Schjørring S, Krogfelt KA. Assessment of bacterial antibiotic resistance transfer in the gut. Int J Microbiol. 2011;2011:1–10.
  • Mazodier P, Davies J. Gene transfer between distantly related bacteria. Annu Rev Genet. 1991;25(1):147–171.
  • Johnson AP, Uttley AH, Woodford N, et al. Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin Microbiol Rev. 1990;3(3):280–291.
  • Serafini F, Bottacini F, Viappiani A, et al. Insights into physiological and genetic mupirocin susceptibility in bifidobacteria. Appl Environ Microbiol. 2011;77(9):3141–3146.
  • Kiwaki M, Sato T. Antimicrobial susceptibility of Bifidobacterium breve strains and genetic analysis of streptomycin resistance of probiotic B. breve strain Yakult. Int J Food Microbiol. 2009;134(3):211–215.
  • Sato T, Iino T. Genetic analyses of the antibiotic resistance of Bifidobacterium bifidum strain Yakult YIT 4007. Int J Food Microbiol. 2010;137(2–3):254–258.
  • Gueimonde M, Flórez AB, van Hoek AH, et al. Genetic basis of tetracycline resistance in Bifidobacterium animalis subsp. lactis. Appl Environ Microbiol. 2010;76(10):3364–3369.
  • Kazimierczak KA, Flint HJ, Scott KP. Comparative analysis of sequences flanking tet (W) resistance genes in multiple species of gut bacteria. Antimicrob Agents Chemother. 2006;50(8):2632–2639.
  • Price CE, Reid SJ, Driessen AJ, et al. The Bifidobacterium longum NCIMB 702259T ctr gene codes for a novel cholate transporter. Appl Environ Microbiol. 2006;72(1):923–926.
  • Hu Y, Yang X, Qin J, et al. Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nat Commun. 2013;4:2151.
  • Aarts H, Margolles A. Antibiotic resistance genes in food and gut (non-pathogenic) bacteria. Bad genes in good bugs. Front Microbiol. 2015;5:754.
  • Guo H, Pan L, Li L, et al. Characterization of antibiotic resistance genes from Lactobacillus isolated from traditional dairy products. J Food Sci. 2017;82(3):724–730.
  • Klare I, Konstabel C, Werner G, et al. Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use. J Antimicrob Chemother. 2007;59(5):900–912.
  • Lee NK, Kim WS, Paik HD. Bacillus strains as human probiotics: characterization, safety, microbiome, and probiotic carrier. Food Sci Biotechnol. 2019;28(5):1297–1305.
  • Dai L, Wu CM, Wang MG, et al. First report of the multidrug resistance gene cfr and the phenicol resistance gene fexA in a Bacillus strain from swine feces. Antimicrob Agents Chemother. 2010;54(9):3953–3955.
  • Sharma J, Goyal A. A study on the drug resistance of probiotic strains isolated from commercial probotic products available in the local market of Agra. Eur J Exp Biol. 2015;5:33–36.
  • Fakruddin MD, Hossain MN, Ahmed MM. Antimicrobial and antioxidant activities of Saccharomyces cerevisiae IFST062013, a potential probiotic. BMC Complement Altern Med. 2017;17(1):64.
  • Chelliah R, Ramakrishnan SR, Prabhu PR, et al. Evaluation of antimicrobial activity and probiotic properties of wild‐strain Pichia kudriavzevii isolated from frozen idli batter. Yeast. 2016;33(8):385–401.
  • Tuohy K, Davies M, Rumsby P, et al. Monitoring transfer of recombinant and nonrecombinant plasmids between Lactococcus lactis strains and members of the human gastrointestinal microbiota in vivo–impact of donor cell number and diet. J Appl Microbiol. 2002;93(6):954–964.
  • Schjørring S, Struve C, Krogfelt KA. Transfer of antimicrobial resistance plasmids from Klebsiella pneumoniae to Escherichia coli in the mouse intestine. J Antimicrob Chemother. 2008;62(5):1086–1093.
  • Cavaco LM, Abatih E, Aarestrup FM, et al. Selection and persistence of CTX-M-producing Escherichia coli in the intestinal flora of pigs treated with amoxicillin, ceftiofur, or cefquinome. Antimicrob Agents Chemother. 2008;52(10):3612–3616.
  • Bidet P, Burghoffer B, Gautier V, et al. In vivo transfer of plasmid-encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an infant and selection of impermeability to imipenem in K. pneumoniae. Antimicrob Agents Chemother. 2005;49(8):3562–3565.
  • Launay A, Ballard SA, Johnson PD, et al. Transfer of vancomycin resistance transposon Tn1549 from Clostridium symbiosum to Enterococcus spp. in the gut of gnotobiotic mice. Antimicrob Agents Chemother. 2006;50(3):1054–1062.
  • Rosander A, Connolly E, Roos S. Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938. Appl Environ Microbiol. 2008;74(19):6032–6040.
  • Topcuoglu S, Gursoy T, Ovalı F, et al. A new risk factor for neonatal vancomycin-resistant Enterococcus colonisation: bacterial probiotics. J Matern Fetal Neonatal Med. 2015;28(12):1491–1494.
  • Basso PJ, Câmara NO, Sales-Campos H. Microbial-based therapies in the treatment of inflammatory bowel disease–an overview of human studies. Front Pharmacol. 2019;9:1571.
  • Schultz M, Sartor RB. Probiotics and inflammatory bowel diseases. Am J Gastroenterol. 2000;95(1):S19–21.
  • Mallon PT, McKay D, Kirk SJ, et al. Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2007;4:CD005573.
  • Sanders ME, Akkermans LM, Haller D, et al. Safety assessment of probiotics for human use. Gut Microbes. 2010;1(3):164–185.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.